Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
Total revenue	$ 130	$ 148
Operating expenses:
Research and development	6,659	10,397
General and administrative	6,021	7,168
Total operating expenses	12,680	17,565
Loss from operations	(12,550)	(17,417)
Other income (expense), net	2,315	5,723
Loss before provision for income taxes	(10,235)	(11,694)
Provision for income taxes	0	0
Net loss	$ (10,235)	$ (11,694)
Series A Convertible Preferred Stock
Operating expenses:
Net loss per share, basic (in dollars per share)	$ (141.57)	$ (162.50)
Net loss per share, diluted (in dollars per share)	$ (141.57)	$ (162.50)
Weighted-average common shares outstanding, basic (in shares)	1,250	1,250
Weighted-average common shares outstanding, diluted (in shares)	1,250	1,250
Common Stock
Operating expenses:
Net loss per share, basic (in dollars per share)	$ (0.14)	$ (0.17)
Net loss per share, diluted (in dollars per share)	$ (0.14)	$ (0.17)
Weighted-average common shares outstanding, basic (in shares)	71,045,265	70,716,929
Weighted-average common shares outstanding, diluted (in shares)	71,045,265	70,716,929